Skip to Content
Merck
CN
  • 2-Arylmethyl-1,4-benzoquinones. II. Novel inhibitors of platelet aggregation: synthesis and pharmacological evaluation.

2-Arylmethyl-1,4-benzoquinones. II. Novel inhibitors of platelet aggregation: synthesis and pharmacological evaluation.

Chemical & pharmaceutical bulletin (1997-04-01)
K Suzuki, T Tatsuoka, T Ishihara, R Ogino, T Miyazaki, F Satoh, S Miyano, K Sumoto
ABSTRACT

Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 micrograms/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 microM.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Benzyloxybromobenzene, 96%